<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">23867462</PMID>
        <DateCompleted>
            <Year>2013</Year>
            <Month>12</Month>
            <Day>10</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1083-351X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>288</Volume>
                    <Issue>35</Issue>
                    <PubDate>
                        <Year>2013</Year>
                        <Month>Aug</Month>
                        <Day>30</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The Journal of biological chemistry</Title>
                <ISOAbbreviation>J. Biol. Chem.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Fused in sarcoma (FUS) protein lacking nuclear localization signal (NLS) and major RNA binding motifs triggers proteinopathy and severe motor phenotype in transgenic mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn>25266-74</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.M113.492017</ELocationID>
            <Abstract>
                <AbstractText>Dysfunction of two structurally and functionally related proteins, FUS and TAR DNA-binding protein of 43 kDa (TDP-43), implicated in crucial steps of cellular RNA metabolism can cause amyotrophic lateral sclerosis (ALS) and certain other neurodegenerative diseases. The proteins are intrinsically aggregate-prone and form non-amyloid inclusions in the affected nervous tissues, but the role of these proteinaceous aggregates in disease onset and progression is still uncertain. To address this question, we designed a variant of FUS, FUS 1-359, which is predominantly cytoplasmic, highly aggregate-prone, and lacks a region responsible for RNA recognition and binding. Expression of FUS 1-359 in neurons of transgenic mice, at a level lower than that of endogenous FUS, triggers FUSopathy associated with severe damage of motor neurons and their axons, neuroinflammatory reaction, and eventual loss of selective motor neuron populations. These pathological changes cause abrupt development of a severe motor phenotype at the age of 2.5-4.5 months and death of affected animals within several days of onset. The pattern of pathology in transgenic FUS 1-359 mice recapitulates several key features of human ALS with the dynamics of the disease progression compressed in line with shorter mouse lifespan. Our data indicate that neuronal FUS aggregation is sufficient to cause ALS-like phenotype in transgenic mice. </AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Shelkovnikova</LastName>
                    <ForeName>Tatyana A</ForeName>
                    <Initials>TA</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Biosciences, Cardiff University, Cardiff, Wales, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Peters</LastName>
                    <ForeName>Owen M</ForeName>
                    <Initials>OM</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Deykin</LastName>
                    <ForeName>Alexey V</ForeName>
                    <Initials>AV</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Connor-Robson</LastName>
                    <ForeName>Natalie</ForeName>
                    <Initials>N</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Robinson</LastName>
                    <ForeName>Hannah</ForeName>
                    <Initials>H</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ustyugov</LastName>
                    <ForeName>Alexey A</ForeName>
                    <Initials>AA</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bachurin</LastName>
                    <ForeName>Sergey O</ForeName>
                    <Initials>SO</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ermolkevich</LastName>
                    <ForeName>Tatyana G</ForeName>
                    <Initials>TG</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Goldman</LastName>
                    <ForeName>Igor L</ForeName>
                    <Initials>IL</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sadchikova</LastName>
                    <ForeName>Elena R</ForeName>
                    <Initials>ER</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kovrazhkina</LastName>
                    <ForeName>Elena A</ForeName>
                    <Initials>EA</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Skvortsova</LastName>
                    <ForeName>Veronica I</ForeName>
                    <Initials>VI</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ling</LastName>
                    <ForeName>Shuo-Chien</ForeName>
                    <Initials>SC</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Da Cruz</LastName>
                    <ForeName>Sandrine</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Parone</LastName>
                    <ForeName>Philippe A</ForeName>
                    <Initials>PA</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Buchman</LastName>
                    <ForeName>Vladimir L</ForeName>
                    <Initials>VL</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ninkina</LastName>
                    <ForeName>Natalia N</ForeName>
                    <Initials>NN</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>075615/Z/04/z</GrantID>
                    <Agency>Wellcome Trust</Agency>
                    <Country>United Kingdom</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2013</Year>
                <Month>07</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Biol Chem</MedlineTA>
            <NlmUniqueID>2985121R</NlmUniqueID>
            <ISSNLinking>0021-9258</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D019913">Nuclear Localization Signals</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D034702">RNA-Binding Protein FUS</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>63231-63-0</RegistryNumber>
                <NameOfSubstance UI="D012313">RNA</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D020816" MajorTopicYN="N">Amino Acid Motifs</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000595" MajorTopicYN="Y">Amino Acid Sequence</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D001369" MajorTopicYN="N">Axons</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003593" MajorTopicYN="N">Cytoplasm</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019913" MajorTopicYN="Y">Nuclear Localization Signals</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012313" MajorTopicYN="N">RNA</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D034702" MajorTopicYN="N">RNA-Binding Protein FUS</DescriptorName>
                <QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017384" MajorTopicYN="Y">Sequence Deletion</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)</Keyword>
            <Keyword MajorTopicYN="N">Animal Models</Keyword>
            <Keyword MajorTopicYN="N">Motor Neuron Disease</Keyword>
            <Keyword MajorTopicYN="N">Neurodegeneration</Keyword>
            <Keyword MajorTopicYN="N">Protein Aggregation</Keyword>
            <Keyword MajorTopicYN="N">Proteinopathy</Keyword>
            <Keyword MajorTopicYN="N">RNA Metabolism</Keyword>
            <Keyword MajorTopicYN="N">RNA-binding Proteins</Keyword>
            <Keyword MajorTopicYN="N">TDP-43</Keyword>
            <Keyword MajorTopicYN="N">Transgenic Mouse</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2013</Year>
                <Month>7</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2013</Year>
                <Month>7</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2013</Year>
                <Month>12</Month>
                <Day>16</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">23867462</ArticleId>
            <ArticleId IdType="pii">M113.492017</ArticleId>
            <ArticleId IdType="doi">10.1074/jbc.M113.492017</ArticleId>
            <ArticleId IdType="pmc">PMC3757190</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Ann N Y Acad Sci. 2000;920:42-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11193175</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Acta Neuropathol. 2013 Feb;125(2):273-88</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22961620</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):10962-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7902575</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2006 Oct 6;314(5796):130-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17023659</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2009 Feb 27;323(5918):1205-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19251627</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2009 Feb 27;323(5918):1208-11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19251628</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Mol Genet. 2009 May 15;18(10):1779-94</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19246516</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Brain. 2009 Nov;132(Pt 11):2922-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19674978</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Acta Neuropathol. 2009 Nov;118(5):605-16</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19669651</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Acta Neuropathol. 2009 Nov;118(5):617-27</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19830439</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Cell Sci. 2010 Apr 15;123(Pt 8):1191-201</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20356930</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Neurol. 2010 Jun;67(6):739-48</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20517935</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Acta Neuropathol. 2011 Mar;121(3):421-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20721566</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS Genet. 2011 Mar;7(3):e1002011</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21408206</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Protein Cell. 2011 Jun;2(6):477-86</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21748598</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Brain. 2011 Sep;134(Pt 9):2548-64</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21752791</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Mol Genet. 2012 Jan 1;21(1):1-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21949354</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurobiol Aging. 2012 May;33(5):1008.e1-15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22118902</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Neurodegener. 2012;7:10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22443542</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2012 Jul 24;109(30):12017-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22778397</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurobiol Dis. 2012 Oct;48(1):124-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22750530</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Neurosci. 2012 Nov;15(11):1488-97</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23023293</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Neurodegener. 2012;7:53</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23046583</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Cell Biol. 2003 Nov;23(22):8233-45</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14585981</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>